FANCL Publishes Health Food Raw Materials’ Place of Origin on Website

FANCL Publishes Health Food Raw Materials’ Place of Origin on Website
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Nutraceutical Clinical Laboratories International, Inc., Secures $2 Million in Funding KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava Rasa Shastra a Potentially Poisonous Alternative An article regarding the recent JAMA article concerning the presence of of lead, mercury and arsenic in ayurvedic medicinces, specifically for the practice of rasa shastra. Commentary from Dr. Robert Saper and Michael McGuffin (AHPA) is included. Rasa Shastra a Potentially Poisonous Alternative An article regarding the recent JAMA article concerning the presence of of lead, mercury and arsenic in ayurvedic medicinces, specifically for the practice of rasa shastra. Commentary from Dr. Robert Saper and Michael McGuffin (AHPA) is included. Rasa Shastra a Potentially Poisonous Alternative An article regarding the recent JAMA article concerning the presence of of lead, mercury and arsenic in ayurvedic medicinces, specifically for the practice of rasa shastra. Commentary from Dr. Robert Saper and Michael McGuffin (AHPA) is included. Rasa Shastra a Potentially Poisonous Alternative An article regarding the recent JAMA article concerning the presence of of lead, mercury and arsenic in ayurvedic medicinces, specifically for the practice of rasa shastra. Commentary from Dr. Robert Saper and Michael McGuffin (AHPA) is included. New Director General for Canada's NHPD As a result of a competitive process, Michelle Boudreau has been selected as Director General of the Natural Health Products Directorate (NHPD) effective September 8, 2008. New Director General for Canada's NHPD As a result of a competitive process, Michelle Boudreau has been selected as Director General of the Natural Health Products Directorate (NHPD) effective September 8, 2008. New Director General for Canada's NHPD As a result of a competitive process, Michelle Boudreau has been selected as Director General of the Natural Health Products Directorate (NHPD) effective September 8, 2008. New Director General for Canada's NHPD As a result of a competitive process, Michelle Boudreau has been selected as Director General of the Natural Health Products Directorate (NHPD) effective September 8, 2008. New Director General for Canada's NHPD As a result of a competitive process, Michelle Boudreau has been selected as Director General of the Natural Health Products Directorate (NHPD) effective September 8, 2008. New Director General for Canada's NHPD As a result of a competitive process, Michelle Boudreau has been selected as Director General of the Natural Health Products Directorate (NHPD) effective September 8, 2008. Cantox to Host Educational Seminar Regarding Section 912: Potential Threat to Food Innovation Cantox Health Sciences International will be hosting a seminar regarding Section 912, part of a law that includes prohibition that represents a shift in the dividing line between foods and drugs, and threatens to present significant hurdles for anyone involved in product development. Cantox to Host Educational Seminar Regarding Section 912: Potential Threat to Food Innovation Cantox Health Sciences International will be hosting a seminar regarding Section 912, part of a law that includes prohibition that represents a shift in the dividing line between foods and drugs, and threatens to present significant hurdles for anyone involved in product development. Cantox to Host Educational Seminar Regarding Section 912: Potential Threat to Food Innovation Cantox Health Sciences International will be hosting a seminar regarding Section 912, part of a law that includes prohibition that represents a shift in the dividing line between foods and drugs, and threatens to present significant hurdles for anyone involved in product development. Cantox to Host Educational Seminar Regarding Section 912: Potential Threat to Food Innovation Cantox Health Sciences International will be hosting a seminar regarding Section 912, part of a law that includes prohibition that represents a shift in the dividing line between foods and drugs, and threatens to present significant hurdles for anyone involved in product development. Cantox to Host Educational Seminar Regarding Section 912: Potential Threat to Food Innovation Cantox Health Sciences International will be hosting a seminar regarding Section 912, part of a law that includes prohibition that represents a shift in the dividing line between foods and drugs, and threatens to present significant hurdles for anyone involved in product development. Cantox to Host Educational Seminar Regarding Section 912: Potential Threat to Food Innovation Cantox Health Sciences International will be hosting a seminar regarding Section 912, part of a law that includes prohibition that represents a shift in the dividing line between foods and drugs, and threatens to present significant hurdles for anyone involved in product development. FTC Sweep Stops Peddlers of Bogus Cancer Cures The Federal Trade Commission has announced 11 law enforcement actions challenging deceptive advertising of bogus cancer cures. The FTC charged the companies with making unsupported claims that their products cured or treated one or more types of cancer. In each case, the company is charged with violating the FTC Act, which bars deceptive claims. Some complaints allege that the companies also falsely touted clinical or scientific proof for their products. FTC Sweep Stops Peddlers of Bogus Cancer Cures The Federal Trade Commission has announced 11 law enforcement actions challenging deceptive advertising of bogus cancer cures. The FTC charged the companies with making unsupported claims that their products cured or treated one or more types of cancer. In each case, the company is charged with violating the FTC Act, which bars deceptive claims. Some complaints allege that the companies also falsely touted clinical or scientific proof for their products. FTC Sweep Stops Peddlers of Bogus Cancer Cures The Federal Trade Commission has announced 11 law enforcement actions challenging deceptive advertising of bogus cancer cures. The FTC charged the companies with making unsupported claims that their products cured or treated one or more types of cancer. In each case, the company is charged with violating the FTC Act, which bars deceptive claims. Some complaints allege that the companies also falsely touted clinical or scientific proof for their products. FTC Sweep Stops Peddlers of Bogus Cancer Cures The Federal Trade Commission has announced 11 law enforcement actions challenging deceptive advertising of bogus cancer cures. The FTC charged the companies with making unsupported claims that their products cured or treated one or more types of cancer. In each case, the company is charged with violating the FTC Act, which bars deceptive claims. Some complaints allege that the companies also falsely touted clinical or scientific proof for their products. FTC Sweep Stops Peddlers of Bogus Cancer Cures The Federal Trade Commission has announced 11 law enforcement actions challenging deceptive advertising of bogus cancer cures. The FTC charged the companies with making unsupported claims that their products cured or treated one or more types of cancer. In each case, the company is charged with violating the FTC Act, which bars deceptive claims. Some complaints allege that the companies also falsely touted clinical or scientific proof for their products. Workshop Clarifies Health Claims Regulations Health claims regulation across Asia and the European Union will come under the spotlight at an upcoming workshop hosted by international food and nutrition policy consultancy EAS. ‘The Practical Implications of Claims Regulations and key steps to successfully accessing markets in Asia & Europe’, will guide companies through the current rules for health claims in key Asian markets and Europe. It is scheduled for November 18, 2008. Workshop Clarifies Health Claims Regulations Health claims regulation across Asia and the European Union will come under the spotlight at an upcoming workshop hosted by international food and nutrition policy consultancy EAS. ‘The Practical Implications of Claims Regulations and key steps to successfully accessing markets in Asia & Europe’, will guide companies through the current rules for health claims in key Asian markets and Europe. It is scheduled for November 18, 2008. Workshop Clarifies Health Claims Regulations Health claims regulation across Asia and the European Union will come under the spotlight at an upcoming workshop hosted by international food and nutrition policy consultancy EAS. ‘The Practical Implications of Claims Regulations and key steps to successfully accessing markets in Asia & Europe’, will guide companies through the current rules for health claims in key Asian markets and Europe. It is scheduled for November 18, 2008. Workshop Clarifies Health Claims Regulations Health claims regulation across Asia and the European Union will come under the spotlight at an upcoming workshop hosted by international food and nutrition policy consultancy EAS. ‘The Practical Implications of Claims Regulations and key steps to successfully accessing markets in Asia & Europe’, will guide companies through the current rules for health claims in key Asian markets and Europe. It is scheduled for November 18, 2008. Workshop Clarifies Health Claims Regulations Health claims regulation across Asia and the European Union will come under the spotlight at an upcoming workshop hosted by international food and nutrition policy consultancy EAS. ‘The Practical Implications of Claims Regulations and key steps to successfully accessing markets in Asia & Europe’, will guide companies through the current rules for health claims in key Asian markets and Europe. It is scheduled for November 18, 2008. Workshop Clarifies Health Claims Regulations Health claims regulation across Asia and the European Union will come under the spotlight at an upcoming workshop hosted by international food and nutrition policy consultancy EAS. ‘The Practical Implications of Claims Regulations and key steps to successfully accessing markets in Asia & Europe’, will guide companies through the current rules for health claims in key Asian markets and Europe. It is scheduled for November 18, 2008. Workshop Clarifies Health Claims Regulations Health claims regulation across Asia and the European Union will come under the spotlight at an upcoming workshop hosted by international food and nutrition policy consultancy EAS. ‘The Practical Implications of Claims Regulations and key steps to successfully accessing markets in Asia & Europe’, will guide companies through the current rules for health claims in key Asian markets and Europe. It is scheduled for November 18, 2008. Workshop Clarifies Health Claims Regulations Health claims regulation across Asia and the European Union will come under the spotlight at an upcoming workshop hosted by international food and nutrition policy consultancy EAS. ‘The Practical Implications of Claims Regulations and key steps to successfully accessing markets in Asia & Europe’, will guide companies through the current rules for health claims in key Asian markets and Europe. It is scheduled for November 18, 2008. Workshop Clarifies Health Claims Regulations Health claims regulation across Asia and the European Union will come under the spotlight at an upcoming workshop hosted by international food and nutrition policy consultancy EAS. ‘The Practical Implications of Claims Regulations and key steps to successfully accessing markets in Asia & Europe’, will guide companies through the current rules for health claims in key Asian markets and Europe. It is scheduled for November 18, 2008. FANCL Establishes Health Food Safety & Quality Standard FANCL Establishes Health Food Safety & Quality Standard FANCL Establishes Health Food Safety & Quality Standard FANCL Establishes Health Food Safety & Quality Standard FANCL Establishes Health Food Safety & Quality Standard Sucralose Manufacturer Confirms United States ITC's Positive Initial Determination In Section 337 Sucralose Patent Infringement Investigation Guangdong Food Industry Institute (GDFII/L&P Food) has announced that Administrative Law Judge Charles E. Bullock of the United States International Trade Commission (ITC) has determined that GDFII/L&P does not infringe any of the patents asserted by Tate & Lyle’s Section 337 complaint (docket# 337-TA-604). The complaint alleges infringement of process patents relating to the production of sucralose and certain intermediate compounds. This initial determination was presented by the US ITC September 22, 2008. Sucralose Manufacturer Confirms United States ITC's Positive Initial Determination In Section 337 Sucralose Patent Infringement Investigation Guangdong Food Industry Institute (GDFII/L&P Food) has announced that Administrative Law Judge Charles E. Bullock of the United States International Trade Commission (ITC) has determined that GDFII/L&P does not infringe any of the patents asserted by Tate & Lyle’s Section 337 complaint (docket# 337-TA-604). The complaint alleges infringement of process patents relating to the production of sucralose and certain intermediate compounds. This initial determination was presented by the US ITC September 22, 2008. Sucralose Manufacturer Confirms United States ITC's Positive Initial Determination In Section 337 Sucralose Patent Infringement Investigation Guangdong Food Industry Institute (GDFII/L&P Food) has announced that Administrative Law Judge Charles E. Bullock of the United States International Trade Commission (ITC) has determined that GDFII/L&P does not infringe any of the patents asserted by Tate & Lyle’s Section 337 complaint (docket# 337-TA-604). The complaint alleges infringement of process patents relating to the production of sucralose and certain intermediate compounds. This initial determination was presented by the US ITC September 22, 2008. Sucralose Manufacturer Confirms United States ITC's Positive Initial Determination In Section 337 Sucralose Patent Infringement Investigation Guangdong Food Industry Institute (GDFII/L&P Food) has announced that Administrative Law Judge Charles E. Bullock of the United States International Trade Commission (ITC) has determined that GDFII/L&P does not infringe any of the patents asserted by Tate & Lyle’s Section 337 complaint (docket# 337-TA-604). The complaint alleges infringement of process patents relating to the production of sucralose and certain intermediate compounds. This initial determination was presented by the US ITC September 22, 2008. Sucralose Manufacturer Confirms United States ITC's Positive Initial Determination In Section 337 Sucralose Patent Infringement Investigation Guangdong Food Industry Institute (GDFII/L&P Food) has announced that Administrative Law Judge Charles E. Bullock of the United States International Trade Commission (ITC) has determined that GDFII/L&P does not infringe any of the patents asserted by Tate & Lyle’s Section 337 complaint (docket# 337-TA-604). The complaint alleges infringement of process patents relating to the production of sucralose and certain intermediate compounds. This initial determination was presented by the US ITC September 22, 2008. Sucralose Manufacturer Confirms United States ITC's Positive Initial Determination In Section 337 Sucralose Patent Infringement Investigation Guangdong Food Industry Institute (GDFII/L&P Food) has announced that Administrative Law Judge Charles E. Bullock of the United States International Trade Commission (ITC) has determined that GDFII/L&P does not infringe any of the patents asserted by Tate & Lyle’s Section 337 complaint (docket# 337-TA-604). The complaint alleges infringement of process patents relating to the production of sucralose and certain intermediate compounds. This initial determination was presented by the US ITC September 22, 2008. Sucralose Manufacturer Confirms United States ITC's Positive Initial Determination In Section 337 Sucralose Patent Infringement Investigation Guangdong Food Industry Institute (GDFII/L&P Food) has announced that Administrative Law Judge Charles E. Bullock of the United States International Trade Commission (ITC) has determined that GDFII/L&P does not infringe any of the patents asserted by Tate & Lyle’s Section 337 complaint (docket# 337-TA-604). The complaint alleges infringement of process patents relating to the production of sucralose and certain intermediate compounds. This initial determination was presented by the US ITC September 22, 2008. Sucralose Manufacturer Confirms United States ITC's Positive Initial Determination In Section 337 Sucralose Patent Infringement Investigation Guangdong Food Industry Institute (GDFII/L&P Food) has announced that Administrative Law Judge Charles E. Bullock of the United States International Trade Commission (ITC) has determined that GDFII/L&P does not infringe any of the patents asserted by Tate & Lyle’s Section 337 complaint (docket# 337-TA-604). The complaint alleges infringement of process patents relating to the production of sucralose and certain intermediate compounds. This initial determination was presented by the US ITC September 22, 2008. Sucralose Manufacturer Confirms United States ITC's Positive Initial Determination In Section 337 Sucralose Patent Infringement Investigation Guangdong Food Industry Institute (GDFII/L&P Food) has announced that Administrative Law Judge Charles E. Bullock of the United States International Trade Commission (ITC) has determined that GDFII/L&P does not infringe any of the patents asserted by Tate & Lyle’s Section 337 complaint (docket# 337-TA-604). The complaint alleges infringement of process patents relating to the production of sucralose and certain intermediate compounds. This initial determination was presented by the US ITC September 22, 2008. Sucralose Manufacturer Confirms United States ITC's Positive Initial Determination In Section 337 Sucralose Patent Infringement Investigation Guangdong Food Industry Institute (GDFII/L&P Food) has announced that Administrative Law Judge Charles E. Bullock of the United States International Trade Commission (ITC) has determined that GDFII/L&P does not infringe any of the patents asserted by Tate & Lyle’s Section 337 complaint (docket# 337-TA-604). The complaint alleges infringement of process patents relating to the production of sucralose and certain intermediate compounds. This initial determination was presented by the US ITC September 22, 2008. Sucralose Manufacturer Confirms United States ITC's Positive Initial Determination In Section 337 Sucralose Patent Infringement Investigation Guangdong Food Industry Institute (GDFII/L&P Food) has announced that Administrative Law Judge Charles E. Bullock of the United States International Trade Commission (ITC) has determined that GDFII/L&P does not infringe any of the patents asserted by Tate & Lyle’s Section 337 complaint (docket# 337-TA-604). The complaint alleges infringement of process patents relating to the production of sucralose and certain intermediate compounds. This initial determination was presented by the US ITC September 22, 2008. Notice to OMB Reflects Industry Concerns About AER Labeling Financial Burden The Natural Products Association has announced that the U.S. Food and Drug Administration (FDA) released a pre-publication notice of proposed collection of information to the Office of Management and Budget (OMB) for review in the pre-published Federal Register online. This submission follows the draft guidance titled “Dietary Supplement Labeling Requirements and Recommendations under the Dietary Supplement and Nonprescription Drug Consumer Protection Act,” which the agency published for comment January 2, 2008. Notice to OMB Reflects Industry Concerns About AER Labeling Financial Burden The Natural Products Association has announced that the U.S. Food and Drug Administration (FDA) released a pre-publication notice of proposed collection of information to the Office of Management and Budget (OMB) for review in the pre-published Federal Register online. This submission follows the draft guidance titled “Dietary Supplement Labeling Requirements and Recommendations under the Dietary Supplement and Nonprescription Drug Consumer Protection Act,” which the agency published for comment January 2, 2008. Notice to OMB Reflects Industry Concerns About AER Labeling Financial Burden The Natural Products Association has announced that the U.S. Food and Drug Administration (FDA) released a pre-publication notice of proposed collection of information to the Office of Management and Budget (OMB) for review in the pre-published Federal Register online. This submission follows the draft guidance titled “Dietary Supplement Labeling Requirements and Recommendations under the Dietary Supplement and Nonprescription Drug Consumer Protection Act,” which the agency published for comment January 2, 2008. Notice to OMB Reflects Industry Concerns About AER Labeling Financial Burden The Natural Products Association has announced that the U.S. Food and Drug Administration (FDA) released a pre-publication notice of proposed collection of information to the Office of Management and Budget (OMB) for review in the pre-published Federal Register online. This submission follows the draft guidance titled “Dietary Supplement Labeling Requirements and Recommendations under the Dietary Supplement and Nonprescription Drug Consumer Protection Act,” which the agency published for comment January 2, 2008. Notice to OMB Reflects Industry Concerns About AER Labeling Financial Burden The Natural Products Association has announced that the U.S. Food and Drug Administration (FDA) released a pre-publication notice of proposed collection of information to the Office of Management and Budget (OMB) for review in the pre-published Federal Register online. This submission follows the draft guidance titled “Dietary Supplement Labeling Requirements and Recommendations under the Dietary Supplement and Nonprescription Drug Consumer Protection Act,” which the agency published for comment January 2, 2008. HHS Preparing to Open FDA Offices in China, India, Europe, and Latin America This Year The U.S. Department of Health and Human Services will send the first U.S. Food and Drug Administration (FDA) staff to China, India, Europe, and Latin America before the end of 2008, HHS Secretary Mike Leavitt has announced. HHS Preparing to Open FDA Offices in China, India, Europe, and Latin America This Year The U.S. Department of Health and Human Services will send the first U.S. Food and Drug Administration (FDA) staff to China, India, Europe, and Latin America before the end of 2008, HHS Secretary Mike Leavitt has announced. HHS Preparing to Open FDA Offices in China, India, Europe, and Latin America This Year The U.S. Department of Health and Human Services will send the first U.S. Food and Drug Administration (FDA) staff to China, India, Europe, and Latin America before the end of 2008, HHS Secretary Mike Leavitt has announced. HHS Preparing to Open FDA Offices in China, India, Europe, and Latin America This Year The U.S. Department of Health and Human Services will send the first U.S. Food and Drug Administration (FDA) staff to China, India, Europe, and Latin America before the end of 2008, HHS Secretary Mike Leavitt has announced. HHS Preparing to Open FDA Offices in China, India, Europe, and Latin America This Year The U.S. Department of Health and Human Services will send the first U.S. Food and Drug Administration (FDA) staff to China, India, Europe, and Latin America before the end of 2008, HHS Secretary Mike Leavitt has announced. New Certification Requirement for Certain Iron-Containing Dietary Supplements Effective Nov. 12, 2008 The “Consumer Product Safety Improvement Act of 2008” (15 U.S.C. § 2063(a)(1)) (CPSIA) requires that products subject to a consumer product safety rule include a Certificate of Compliance when shipped in commerce on and after Nov.12, 2008. For dietary supplement manufacturers, products subject to a consumer product safety rule are those that contain over 250 mg of elemental iron and are required to be in childproof closures by regulations promulgated under the “Poison Prevention Packaging Act,” a statute administered by the U.S. Consumer Product Safety Commission (CPSC). New Certification Requirement for Certain Iron-Containing Dietary Supplements Effective Nov. 12, 2008 The “Consumer Product Safety Improvement Act of 2008” (15 U.S.C. § 2063(a)(1)) (CPSIA) requires that products subject to a consumer product safety rule include a Certificate of Compliance when shipped in commerce on and after Nov.12, 2008. For dietary supplement manufacturers, products subject to a consumer product safety rule are those that contain over 250 mg of elemental iron and are required to be in childproof closures by regulations promulgated under the “Poison Prevention Packaging Act,” a statute administered by the U.S. Consumer Product Safety Commission (CPSC). New Certification Requirement for Certain Iron-Containing Dietary Supplements Effective Nov. 12, 2008 The “Consumer Product Safety Improvement Act of 2008” (15 U.S.C. § 2063(a)(1)) (CPSIA) requires that products subject to a consumer product safety rule include a Certificate of Compliance when shipped in commerce on and after Nov.12, 2008. For dietary supplement manufacturers, products subject to a consumer product safety rule are those that contain over 250 mg of elemental iron and are required to be in childproof closures by regulations promulgated under the “Poison Prevention Packaging Act,” a statute administered by the U.S. Consumer Product Safety Commission (CPSC). New Certification Requirement for Certain Iron-Containing Dietary Supplements Effective Nov. 12, 2008 The “Consumer Product Safety Improvement Act of 2008” (15 U.S.C. § 2063(a)(1)) (CPSIA) requires that products subject to a consumer product safety rule include a Certificate of Compliance when shipped in commerce on and after Nov.12, 2008. For dietary supplement manufacturers, products subject to a consumer product safety rule are those that contain over 250 mg of elemental iron and are required to be in childproof closures by regulations promulgated under the “Poison Prevention Packaging Act,” a statute administered by the U.S. Consumer Product Safety Commission (CPSC). New Certification Requirement for Certain Iron-Containing Dietary Supplements Effective Nov. 12, 2008 The “Consumer Product Safety Improvement Act of 2008” (15 U.S.C. § 2063(a)(1)) (CPSIA) requires that products subject to a consumer product safety rule include a Certificate of Compliance when shipped in commerce on and after Nov.12, 2008. For dietary supplement manufacturers, products subject to a consumer product safety rule are those that contain over 250 mg of elemental iron and are required to be in childproof closures by regulations promulgated under the “Poison Prevention Packaging Act,” a statute administered by the U.S. Consumer Product Safety Commission (CPSC). New Certification Requirement for Certain Iron-Containing Dietary Supplements Effective Nov. 12, 2008 The “Consumer Product Safety Improvement Act of 2008” (15 U.S.C. § 2063(a)(1)) (CPSIA) requires that products subject to a consumer product safety rule include a Certificate of Compliance when shipped in commerce on and after Nov.12, 2008. For dietary supplement manufacturers, products subject to a consumer product safety rule are those that contain over 250 mg of elemental iron and are required to be in childproof closures by regulations promulgated under the “Poison Prevention Packaging Act,” a statute administered by the U.S. Consumer Product Safety Commission (CPSC). New Certification Requirement for Certain Iron-Containing Dietary Supplements Effective Nov. 12, 2008 The “Consumer Product Safety Improvement Act of 2008” (15 U.S.C. § 2063(a)(1)) (CPSIA) requires that products subject to a consumer product safety rule include a Certificate of Compliance when shipped in commerce on and after Nov.12, 2008. For dietary supplement manufacturers, products subject to a consumer product safety rule are those that contain over 250 mg of elemental iron and are required to be in childproof closures by regulations promulgated under the “Poison Prevention Packaging Act,” a statute administered by the U.S. Consumer Product Safety Commission (CPSC). AHPA Adopts New Trade Recommendation; Guidance on Heavy Metal, Microbiological Limits The Board of Trustees of the American Herbal Products Association (AHPA) adopted several self-regulatory measures during its Oct. 15 meeting in Boston that expand the association’s list of trade recommendations and guidance documents, namely a trade recommendation on the use of the word “extract,” an interim guidance on heavy metal limits and a guidance policy on microbiological limits. AHPA Adopts New Trade Recommendation; Guidance on Heavy Metal, Microbiological Limits The Board of Trustees of the American Herbal Products Association (AHPA) adopted several self-regulatory measures during its Oct. 15 meeting in Boston that expand the association’s list of trade recommendations and guidance documents, namely a trade recommendation on the use of the word “extract,” an interim guidance on heavy metal limits and a guidance policy on microbiological limits. AHPA Adopts New Trade Recommendation; Guidance on Heavy Metal, Microbiological Limits The Board of Trustees of the American Herbal Products Association (AHPA) adopted several self-regulatory measures during its Oct. 15 meeting in Boston that expand the association’s list of trade recommendations and guidance documents, namely a trade recommendation on the use of the word “extract,” an interim guidance on heavy metal limits and a guidance policy on microbiological limits. EAS Helps Companies Clarify Procedures for Marketing Food Supplements in Europe Food supplement companies from across Europe gathered in Brussels this month for a workshop on how to master the European Union’s changing regulatory environment for their products. EAS Helps Companies Clarify Procedures for Marketing Food Supplements in Europe Food supplement companies from across Europe gathered in Brussels this month for a workshop on how to master the European Union’s changing regulatory environment for their products. EAS Helps Companies Clarify Procedures for Marketing Food Supplements in Europe Food supplement companies from across Europe gathered in Brussels this month for a workshop on how to master the European Union’s changing regulatory environment for their products. EAS Helps Companies Clarify Procedures for Marketing Food Supplements in Europe Food supplement companies from across Europe gathered in Brussels this month for a workshop on how to master the European Union’s changing regulatory environment for their products. Peer-Reviewed Published Study Demonstrates Safety of UC-II® A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe. Peer-Reviewed Published Study Demonstrates Safety of UC-II® A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe. BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel. Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel. Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel. Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel. Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel. Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel. Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel. ISO14001 certification granted to Indena Indena has been granted the ISO14001 certification for its main production site of Settala (Milan). ISO14001 certification granted to Indena Indena has been granted the ISO14001 certification for its main production site of Settala (Milan). ISO14001 certification granted to Indena Indena has been granted the ISO14001 certification for its main production site of Settala (Milan). ISO14001 certification granted to Indena Indena has been granted the ISO14001 certification for its main production site of Settala (Milan). ISO14001 certification granted to Indena Indena has been granted the ISO14001 certification for its main production site of Settala (Milan). New Company for “Change-The-World” Entrepreneurs™ Launches GMP Labs Expands Liquid Nutraceutical Capabilities What Parents Should Know About Kids and Supplements What Parents Should Know About Kids and Supplements Oats Beat Back Cholesterol Oats Beat Back Cholesterol Seniors: Pump Up for Strong Bones and Heart Seniors: Pump Up for Strong Bones and Heart	From 16 September 2008, FANCL Corp. will be publishing information regarding the place of origin and processing of their supplements, aojiru (kale juice), and germinated brown rice products on their homepage for the general public. Realizing that consumer confidence has been rocked due to the repeated occurrences regarding false place of origin/expiry dates and adulteration by pesticides, these proactive information disclosure efforts are being made in the hope that consumers will have peace of mind when using the products. This is the first time that a major corporation such as this, with a health food line-up of over 100 products (that include over 400 different raw materials), has publicly released information on area of origin and processing.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software